{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:45:03Z","timestamp":1791290703801,"version":"4.3.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:00:00Z","timestamp":1431388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.04.100","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T04:30:27Z","timestamp":1431577827000},"page":"3200-3207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis"],"prefix":"10.1016","volume":"33","author":[{"given":"Dora","family":"Estripeaut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Tinajeros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Mercedes","family":"Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakrudeen","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ortega-Barria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"DeAntonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.04.100_bib0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5812\/hepatmon.5940","article-title":"Changing pattern of hepatitis a virus epidemiology in an area of high endemicity","volume":"12","author":"Campagna","year":"2012","journal-title":"Hepat Mon"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0205","series-title":"Global policy report on the prevention and control of viral hepatitis. WHO member states","author":"Global policy report on the prevention and control of viral hepatitis","year":"2013"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0210","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4254\/wjh.v4.i3.68","article-title":"Epidemiology and prevention in developing countries","volume":"4","author":"Franco","year":"2012","journal-title":"World J Hepatol"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vaccine.2012.04.104","article-title":"Long-term protective effects of hepatitis A vaccines. A systematic review","volume":"31","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0220","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0225","series-title":"Hepatitis A","author":"Hepatitis A","year":"2000"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0230","series-title":"The global prevalence of Hepatitis A virus infection and susceptibility: a systematic review","author":"The global prevalence of Hepatitis A virus infection and susceptibility","year":"2010"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0235","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1016\/j.vaccine.2010.08.037","article-title":"A virus seroprevalence by age and world region, 1990 and 2005","volume":"28","author":"Jacobsen","year":"2010","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.04.100_bib0240","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0264-410X(99)00466-1","article-title":"A shifting epidemiology in Latin America","volume":"18","author":"Tanaka","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0245","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4161\/hv.21909","article-title":"Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive(R)","volume":"8","author":"Wu","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0250","series-title":"Manual of rules and procedures: expanded program on immunization 2012","author":"MINSA","year":"2015"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.inf.0000247105.45185.13","article-title":"Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program","volume":"26","author":"Belmaker","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0260","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/INF.0b013e31815efe4b","article-title":"Universal hepatitis A vaccination in the United States: a call for action","volume":"27","author":"Lieberman","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0265","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/INF.0000000000000042","article-title":"Impact of the single-dose immunization strategy against hepatitis A in Argentina","volume":"33","author":"Vizzotti","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0270","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.294.2.202","article-title":"Incidence of hepatitis A in Israel following universal immunization of toddlers","volume":"294","author":"Dagan","year":"2005","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2015.04.100_bib0275","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2893.2008.01032.x","article-title":"Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program","volume":"15","author":"Chodick","year":"2008","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.vaccine.2015.04.100_bib0280","first-page":"115","article-title":"Prevenci\u00f3n de hepatitis A mediante vacunaci\u00f3n en Uruguay (2005\u20132010)","volume":"28","author":"Romero","year":"2012","journal-title":"Rev M\u00e9d Urug"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0285","series-title":"Gobierno nacional \u2013 Ministerio de Salud Republica de Panama","author":"Gobierno nacional","year":"2015"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0290","series-title":"International statistical classification of diseases and related health problems 10th revision","author":"International Statistical Classification","year":"2015"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0295","series-title":"International classification of diseases, ninth revision (ICD-9)","author":"International Classification of Diseases","year":"2015"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0300","unstructured":"Contralori\u00e1 general de la rep\u00fablica de Panam\u00e1. Available at: http:\/\/www.contraloria.gob.pa\/ [accessed on 24.02.15]"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0305","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1016\/j.vaccine.2008.08.066","article-title":"A statistical model to estimate the impact of a hepatitis A vaccination programme","volume":"26","author":"Oviedo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0310","series-title":"An introduction to categorical data analysis","author":"Agresti","year":"2007"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0315","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1590\/S0074-02762012000500012","article-title":"Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil","volume":"107","author":"Vitral","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.vaccine.2015.04.100_bib0320","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4161\/hv.22774","article-title":"Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: implications for hepatitis A vaccination","volume":"9","author":"Lazcano-Ponce","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0325","series-title":"WHO recommendations summary of WHO position papers\u2014recommendations for routine immunization","author":"WHO","year":"2015"},{"issue":"3","key":"10.1016\/j.vaccine.2015.04.100_bib0330","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4161\/hv.18617","article-title":"Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine","volume":"8","author":"Van Herck","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2015.04.100_bib0335","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/jmv.22200","article-title":"Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years","volume":"83","author":"Van Herck","year":"2011","journal-title":"J Med Virol."},{"issue":"8","key":"10.1016\/j.vaccine.2015.04.100_bib0340","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4161\/hv.20549","article-title":"Model-based projections of the population-level impact of hepatitis A vaccination in Mexico","volume":"8","author":"Van Effelterre","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"13","key":"10.1016\/j.vaccine.2015.04.100_bib0345","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.vaccine.2013.10.088","article-title":"Model based estimates of long-term persistence of inactivatedhepatitis A vaccine-induced antibodies in adults","volume":"14","author":"Hens","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0350","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/infdis\/jis710","article-title":"Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series","volume":"207","author":"Raczniak","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0355","series-title":"SAGE Hepatitis A working group report","author":"SAGE","year":"2015"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0360","series-title":"Situaci\u00f3n de salud de Panam\u00e1 2013 \u2013 Ministerio de Salud","year":"2015"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0365","series-title":"CDC: viral hepatitis statistics & surveillance","article-title":"Surveillance for viral hepatitis\u2014United States, 2011","author":"CDC","year":"2011"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2015.04.100_bib0370","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2893.2008.01029.x","article-title":"Incidence of Hepatitis A in Argentina after vaccination","volume":"15","author":"Vacchino","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2015.04.100_bib0375","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jama.294.2.246","article-title":"Effect of hepatitis A vaccination programs","volume":"294","author":"Van Damme","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2015.04.100_bib0380","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.294.2.194","article-title":"Incidence of hepatitis A in the United States in the era of vaccination","volume":"294","author":"Wasley","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2015.04.100_bib0385","first-page":"141","article-title":"Hepatitis A vaccination coverage among children aged 14\u201335 months\u2014United States, 2003","volume":"54","author":"Centers for disease control and prevention (CDC)","year":"2005","journal-title":"MMWR"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.04.100_bib0390","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1093\/infdis\/171.Supplement_1.S40","article-title":"Efficacy of an inactivated hepatitis A vaccine in pre- and postexposure conditions in marmosets","volume":"171","author":"D\u2019Hondt","year":"1995","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T16:26:37Z","timestamp":1537633597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15006106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":39,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0264410X15006106"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.100","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}